IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.370
-0.030 (-2.14%)
Jul 11, 2025, 1:02 PM - Market open
IO Biotech Employees
IO Biotech had 80 employees as of December 31, 2024. The number of employees increased by 12 or 17.65% compared to the previous year.
Employees
80
Change (1Y)
12
Growth (1Y)
17.65%
Revenue / Employee
n/a
Profits / Employee
-$1,230,688
Market Cap
90.26M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 80 | 12 | 17.65% |
Dec 31, 2023 | 68 | 11 | 19.30% |
Dec 31, 2022 | 57 | 25 | 78.13% |
Dec 31, 2021 | 32 | 21 | 190.91% |
Dec 31, 2020 | 11 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IOBT News
- 7 weeks ago - IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 2 months ago - IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 - GlobeNewsWire
- 2 months ago - IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 - GlobeNewsWire
- 3 months ago - IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 4 months ago - IO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025 - GlobeNewsWire
- 4 months ago - IO Biotech Reports 2024 Business Highlights - GlobeNewsWire
- 4 months ago - IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference - GlobeNewsWire